Glaxosmithkline Share Price | |
---|---|
Price | 1,639.00 |
Bid | 1,638.50 |
Ask | 1,639.00 |
Change | -0.50 (-0.03%) |
Volume | 1,173,976 |
Open | 1,650.50 |
High | 1,656.00 |
Low | 1,637.00 |
Prev. Close | 1,639.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £66.97b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 3,324 |
---|---|
Vol. Sold | 499,869 |
Sold Value | £8.24m |
Vol. Bought | 562,875 |
Bought Value | £9.28m |
PE Ratio | 13.47862 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.386% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
23-Apr-24 | 14:17:19 | 1,639.00 | 321 | Sell* | 1,639.00 | 1,639.50 | 5,261 | A Automatic Execution |
23-Apr-24 | 14:15:46 | 1,640.00 | 10 | Buy* | 1,639.00 | 1,640.00 | 164.00 | A Automatic Execution |
23-Apr-24 | 14:15:44 | 1,639.4394 | 900 | Sell* | 1,639.00 | 1,640.00 | 14.75k | O Ordinary |
23-Apr-24 | 14:15:37 | 1,639.99 | 1 | Buy* | 1,639.00 | 1,640.00 | 16.40 | O Ordinary |
23-Apr-24 | 14:15:36 | 1,639.50 | 105 | Unknown* | 1,639.00 | 1,640.00 | 1,721 | O Ordinary |
23-Apr-24 | 14:15:16 | 1,639.50 | 246 | Buy* | 1,639.00 | 1,639.50 | 4,033 | A Automatic Execution |
23-Apr-24 | 14:15:16 | 1,639.50 | 73 | Buy* | 1,639.00 | 1,639.50 | 1,197 | A Automatic Execution |
23-Apr-24 | 14:15:16 | 1,639.50 | 175 | Buy* | 1,639.00 | 1,639.50 | 2,869 | A Automatic Execution |
23-Apr-24 | 14:15:09 | 1,639.50 | 473 | Sell* | 1,639.50 | 1,640.00 | 7,755 | A Automatic Execution |
23-Apr-24 | 14:15:09 | 1,639.50 | 429 | Sell* | 1,639.50 | 1,640.00 | 7,033 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together